share_log

5 Value Stocks To Watch In The Healthcare Sector

5 Value Stocks To Watch In The Healthcare Sector

醫療保健板塊中值得關注的5只價值股
Benzinga Real-time News ·  2022/08/08 10:50

 

Â

The Meaning Behind Value Stocks

價值型股票背後的意義

A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.

傳統上,價值型股票的定義是市場上的投資者如何評估該公司未來的增長前景。較低的市盈率是表明該公司被低估的良好基本指標,很可能被貼上價值股的標籤。

The following stocks are considered to be notable value stocks in the healthcare sector:

以下股票被認為是醫療保健板塊中值得注意的價值股:

  1. Iterum Therapeutics (NASDAQ:ITRM) - P/E: 1.13
  2. Viracta Therapeutics (NASDAQ:VIRX) - P/E: 2.89
  3. Achilles Therapeutics (NASDAQ:ACHL) - P/E: 0.51
  4. CVRx (NASDAQ:CVRX) - P/E: 0.14
  5. Cross Country Healthcare (NASDAQ:CCRN) - P/E: 4.23
  1. Iterum治療學納斯達克:ITRM)-市盈率:1.13
  2. 維拉克塔治療公司(納斯達克:virx)-市盈率:2.89
  3. 阿喀琉斯治療學納斯達克:ACHL-市盈率:0.51
  4. CVRx(納斯達克:CVRx)-市盈率:0.14
  5. 越野醫療(納斯達克:CCRN)-市盈率:4.23

Iterum Therapeutics saw a decrease in earnings per share from -0.02 in Q4 to $-0.03 now. Viracta Therapeutics has reported Q1 earnings per share at $-0.28, which has increased by 9.68% compared to Q4, which was -0.31. Achilles Therapeutics has been featured as a value stock. Achilles Therapeutics's Q1 EPS sits at $-0.45, which has not changed since last quarter (Q4). CVRx saw a decrease in earnings per share from -0.49 in Q1 to $-0.54 now. Cross Country Healthcare saw a decrease in earnings per share from 1.7 in Q1 to $1.4 now.

Iterum治療公司的每股收益從第四季度的-0.02美元下降到現在的-0.03美元。維拉克塔治療公司公佈第一季度每股收益為-0.28美元,與第四季度的-0.31美元相比增長了9.68%。阿喀琉斯治療公司一直被列為價值型股票。阿喀琉斯治療公司第一季度每股收益為-0.45美元,自上一季度以來一直沒有變化(第四季度)。CVRx的每股收益從第一季度的-0.49美元下降到現在的-0.54美元。CrossCountry Healthcare的每股收益從第一季度的1.7美元下降到現在的1.4美元。

These 5 value stocks were selected by Benzinga Insights based on quantified analysis. While this methodical judgment process is not meant to make final decisions, our technology can give investors additional perception into the sector.

這5只價值型股票是由Benzinga洞察基於量化分析。雖然這種有條不紊的判斷過程並不意味着做出最終決定,但我們的技術可以讓投資者對該行業有更多的看法。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論